Schonfeld Strategic Advisors’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-5,573
| Closed | -$228K | – | 2176 |
|
|
2024
Q2 | $228K | Buy |
+5,573
| New | +$228K | ﹤0.01% | 1640 |
|
|
2024
Q1 | – | Sell |
-130,117
| Closed | -$1.18M | – | 2136 |
|
|
2023
Q4 | $1.18M | Buy |
130,117
+2,817
| +2% | +$25.5K | 0.01% | 906 |
|
|
2023
Q3 | $812K | Sell |
127,300
-7,699
| -6% | -$49.1K | 0.01% | 957 |
|
|
2023
Q2 | $1.5M | Buy |
+134,999
| New | +$1.5M | 0.01% | 854 |
|
|
2023
Q1 | – | Sell |
-10,700
| Closed | -$237K | – | 2457 |
|
|
2022
Q4 | $237K | Buy |
+10,700
| New | +$237K | ﹤0.01% | 1885 |
|
|
2022
Q1 | – | Sell |
-19,531
| Closed | -$464K | – | 2665 |
|
|
2021
Q4 | $464K | Buy |
+19,531
| New | +$464K | ﹤0.01% | 1233 |
|
|
2021
Q1 | – | Sell |
-49,110
| Closed | -$1.25M | – | 2011 |
|
|
2020
Q4 | $1.25M | Buy |
+49,110
| New | +$1.25M | 0.02% | 700 |
|